Jiangxi Fushine Pharmaceutical Co Ltd Class A 300497
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 12.23
- Day Range
- CNY 11.70–12.17
- 52-Week Range
- CNY 5.62–14.33
- Bid/Ask
- CNY 11.96 / CNY 11.97
- Market Cap
- CNY 6.58 Bil
- Volume/Avg
- 22.3 Mil / 11.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.18
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Jiangxi Fushine Pharmaceutical Co Ltd is engaged in research and development, manufactures and sells APIs and pharmaceutical intermediates. It offers penicillin, carbapenem, and other products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 2,179
- Website
- http://www.fushine.cn
Comparables
Valuation
|
Metric
|
300497
|
603566
|
300966
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 59.44 | 74.75 |
Price/Book Value | 2.71 | 2.64 | 2.48 |
Price/Sales | 4.18 | 6.18 | 4.02 |
Price/Cash Flow | 63.17 | 29.79 | 22.58 |
Price/Earnings
300497
603566
300966
Financial Strength
|
Metric
|
300497
|
603566
|
300966
|
|---|---|---|---|
Quick Ratio | 1.09 | 2.52 | 0.73 |
Current Ratio | 1.48 | 3.00 | 1.61 |
Interest Coverage | −3.82 | — | 1.78 |
Quick Ratio
300497
603566
300966
Profitability
|
Metric
|
300497
|
603566
|
300966
|
|---|---|---|---|
Return on Assets (Normalized) | −3.63% | 3.63% | 1.28% |
Return on Equity (Normalized) | −6.86% | 4.33% | 3.05% |
Return on Invested Capital (Normalized) | −3.45% | 4.16% | 2.03% |
Return on Assets
300497
603566
300966
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Xmpnpflmxl | Tccw | $586.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Cyflhmj | Qzxlpft | $110.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Cxkykfn | Fhwcw | $107.6 Bil | |
MRNA
| Moderna Inc | Mlhfxtbt | Jzvgn | $48.2 Bil | |
BNTX
| BioNTech SE ADR | Ffmkxgpn | Xxyv | $22.2 Bil | |
ARGX
| argenx SE ADR | Cnkmqqsfm | Tzcw | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Txzxghz | Nmmddl | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Czhfgpmph | Cdgqh | $15.1 Bil | |
INCY
| Incyte Corp | Mbhgthry | Gmdzyv | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Vltwdpyb | Bwjspg | $12.7 Bil |